Abstract

Sucrose provides both sweetness and energy by binding to both Venus flytrap domains (VFD) of the heterodimeric sweet taste receptor (T1R2/T1R3). In contrast, non-caloric sweeteners such as sucralose and aspartame only bind to one specific domain (VFD2) of T1R2, resulting in high-intensity sweetness. In this study, we investigate the binding mechanism of various steviol glycosides, artificial sweeteners, and a negative allosteric modulator (lactisole) at four distinct binding sites: VFD2, VFD3, transmembrane domain 2 (TMD2), and TMD3 through binding experiments and computational docking studies. Our docking results reveal multiple binding sites for the tested ligands, including the radiolabeled ligands. Our experimental evidence demonstrates that the C20 carboxy terminus of the Gα protein can bind to the intracellular region of either TMD2 or TMD3, altering GPCR affinity to the high-affinity state for steviol glycosides. These findings provide a mechanistic understanding of the structure and function of this heterodimeric sweet taste receptor.

Sucrose and other non-caloric sweeteners can bind to different domains of the heterodimeric sweet taste receptor (T1R2/T1R3), resulting in different levels of sweetness. Here, the authors investigate the binding mechanism of various steviol glycosides, artificial sweeteners, and a negative allosteric modulator (lactisole) at four distinct binding sites of T1R2/T1R3 through binding experiments and computational docking studies, revealing multiple binding sites for the tested ligands and structural– function correlations of ligand–receptor interactions.

Details

Title
Steviol rebaudiosides bind to four different sites of the human sweet taste receptor (T1R2/T1R3) complex explaining confusing experiments
Author
Hao, Shuang 1 ; Guthrie, Brian 2 ; Kim, Soo-Kyung 3   VIAFID ORCID Logo  ; Balanda, Sergej 4 ; Kubicek, Jan 4 ; Murtaza, Babar 5   VIAFID ORCID Logo  ; Khan, Naim A. 5   VIAFID ORCID Logo  ; Khakbaz, Pouyan 6 ; Su, Judith 1   VIAFID ORCID Logo  ; Goddard, William A. 3   VIAFID ORCID Logo 

 The University of Arizona, Wyant College of Optical Sciences and Department of Biomedical Engineering, Tucson, USA (GRID:grid.134563.6) (ISNI:0000 0001 2168 186X) 
 Global Core Research and Development Group, Plymouth, USA (GRID:grid.134563.6) 
 California Institute of Technology, Materials and Process Simulation Center (MSC), Pasadena, USA (GRID:grid.20861.3d) (ISNI:0000 0001 0706 8890) 
 Creative Campus Monheim, Cube Biotech, Monheim, Germany (GRID:grid.20861.3d) 
 Université de Bourgogne, Physiologie de Nutrition & Toxicologie, UB 1231 Center for Translational & Molecular Medicine (CTM), 21000 Dijon, France (GRID:grid.5613.1) (ISNI:0000 0001 2298 9313) 
 Global Core Research and Development Group, Plymouth, USA (GRID:grid.5613.1) 
Pages
236
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
23993669
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3118122319
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.